Neuropeptide Y inhibits spontaneous α-melanocyte-stimulating hormone (α-MSH) release via a Y5 receptor and suppresses thyrotropin-releasing hormone-induced α-MSH secretion via a Y1 receptor in frog melanotrope cells

Endocrinology

Volumn 143, Issue 5, 2002, Pages 1686-1694

  Galas, Ludovic ^a   Tonon, Marie Christine ^a   Beaujean, Delphine ^a   Fredriksson, Robert ^b   Larhammar, Dan ^b   Lihrmann, Isabelle ^a   Jegou, Sylvie ^a   Fournier, Alain ^c   Chartrel, Nicolas ^a   Vaudry, Hubert ^a,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b UPPSALA UNIVERSITY   (Sweden)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALPHA INTERMEDIN; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; OMEGA CONOTOXIN; PERTUSSIS TOXIN; PROTIRELIN; RECEPTOR SUBTYPE;

AMPHIBIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; FROG; HISTOCHEMISTRY; HORMONE RELEASE; HYPOPHYSIS INTERMEDIATE LOBE; IN SITU HYBRIDIZATION; INHIBITION KINETICS; MELANOTROPE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECRETORY CELL; SPECIES DIFFERENCE; SWINE;

EID: 18344362983     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.5.8761     Document Type: Article

References (69)

1. Multihormonal regulation of pituitary melanotrophs
2. Adaptation physiology: The functioning of pituitary melanotrope cells during background adaptation of the amphibian Xenopus laevis
3. The melanotrope cell of the frog pituitary as a model of neuroendocrine integration
4. Background adaptation by Xenopus laevis: A model for studying neuronal information processing in the pituitary pars intermedia
5. Distribution of immunoreactive thyrotropin-releasing hormone in the forebrain and hypophysis of the bullfrog, Rana catesbeiana
6. Assessment of TRH as a potential MSH release stimulating factor in Xenopus laevis
7. Three distinct TRH-immunoreactive axonal systems project in the median eminence-pituitary complex of the frog Rana ridibunda. Immunocytochemical evidence for co-localization of TRH and mesotocin in fibers innervating pars intermedia cells
8. Neuropeptide Y in the intermediate lobe of the frog pituitary acts as an α-MSH-release inhibiting factor
9. Neuropeptide Y (NPY)-like immunoreactive neurons in the brain and pituitary of the amphibian Rana catesbeiana
10. A NPY-like peptide may function as MSH-release inhibiting factor in Xenopus laevis
11. Demonstration of coexisting catecholamine (dopamine), amino acid (GABA), and peptide (NPY) involved in inhibition of melanotrope cell activity in Xenopus laevis: A quantitative ultrastructural, freeze-substitution immunocytochemical study
12. Colocalization of tyrosine hydroxylase, GABA and neuropeptide Y within axon terminals innervating the intermediate lobe of the frog Rana ridibunda
13. Thyrotropin-releasing hormone stimulates the release of melanotropin from frog neurointermediate lobe in vitro
14. Catecholaminergic control of α-melanocyte-stimulating hormone (α-MSH) release by frog neurointermediate lobe in vitro: Evidence for direct stimulation of α-MSH release by thyrotropin-releasing hormone
15. Molecular and cellular biology of thyrotropin-releasing hormone receptors
16. A novel transcript for the thyrotropin-releasing hormone receptor in human pituitary and pituitary tumors
17. Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor
18. Cloning and characterization of a new subtype of thyrotropin-releasing hormone receptors
19. Y-Receptor subtypes - How many more?
20. International union of pharmacological recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
21. Origins of the many NPY-family receptors in mammals
22. 5 receptor subtype
23. Role of inositol lipid second messengers in regulation of secretion: Studies of thyrotropin-releasing hormone action in pituitary cells
24. Characterization of the calcium response to thyrotropin-releasing hormone in lactotrophs and GH cells
25. Thyroliberin receptor binding and adenylyl cyclase activation in cultured prolactin-producing rat pituitary tumor cells (GH cells)
26. 3 rat pituitary tumor cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking of the stimulatory guanine-nucleotide-binding protein
27. 3 cells
28. Dopamine inhibits the arachidonate and prolactin release stimulated by thyrotropin-releasing hormone through an islet-activating protein-sensitive GTP-binding protein in anterior pituitary cells
29. 3 cells
30. 3 cells
31. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine
32. 3 cells by divergent pathways
33. A G protein βγ dimer-mediated pathway contributes to mitogen-activated protein kinase activation by thyrotropin-releasing hormone receptors in transfected COS-7 cells
34. 2+ in SK-N-MC cells by three different mechanisms
35. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways
36. Neuropeptide Y increases intracellular calcium in rat pinealocytes
37. 2+ channels in acutely isolated neurons from the rat arcuate nucleus
38. 2+ in heart and vascular smooth muscle cells
39. Coronary constriction due to neuropeptide Y: Alleviation with cyclooxygenase blockers
40. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y
41. 2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line
42. + channels in vascular smooth muscle cells by neuropeptide Y
43. Neuropeptlde-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells
44. 1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors
45. Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: Homology with human neuropeptide Y
46. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
47. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals
48. Subunit composition and pharmacological characterization of γ-aminobutyric acid type A receptors in frog pituitary melanotrophs
49. Effect of vasotocin on cytosolic free calcium concentrations in frog adrenocortical cells in primary culture
50. 2+ indicators with greatly improved fluorescence properties
51. 2+ transients using simultaneous dual-emission microspectrofluorimetry and electrophysiology in individual pituitary cells
52. Mechanism of action of γ-aminobutyric acid on frog melanotrophs
53. Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia
54. Biological and radioimmunological evidence for melanocyte-stimulating hormones (MSH) of extrapituitary origin in the rat brain
55. 4 receptors causes calcium influx in adrenocortical cells: Involvement of calcium in 5-hydroxytryptamine-induced steroid secretion
56. Involvement of extracellular and intracellular calcium sources in TRH-induced α-MSH secretion from frog melanotrope cells
57. 1 cDNA from Xenopus laevis
58. 2 receptor
59. Neuropeptide Y inhibits thyrotropin-releasing hormone-induced stimulation of melanotropin release from the intermediate lobe of the frog pituitary
60. Identification of a GTP-binding protein alpha subunit that lacks an apparent ADP-ribosylation site for pertussis toxin
61. Gz, a guanine nucleotide-binding protein with unique biochemical properties
62. Involvement of protein kinase C and protein tyrosine kinase in TRH-induced α-MSH secretion from frog melanotrope cells
63. Dopamine inhibits TRH-induced MAP kinase activation in dispersed rat anterior pituitary cells
64. Morphological and functional heterogeneity of frog melanotrope cells
65. Two frog melanotrope cell subpopulations exhibiting distinct biochemical and physiological patterns in basal conditions and under thyrotropin-releasing hormone stimulation
66. 2+ currents
67. 1 receptor
68. Dopamine has no effect on thyrotropin-releasing hormone mobilization of calcium from intracellular stores in rat anterior pituitary cells
69. 2+ transients induced by thyrotropin-releasing hormone rapidly lose their ability to cause release of prolactin